NeuroOne Medical Technologies Corporation Completes $12M Underwritten Registered Public Offering

NeuroOne Medical Technologies Corporation, a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced pricing of an underwritten registered public offering of 3,750,000 shares of its common stock at a price of $3.20 per share. Faegre Drinker represented Craig-Hallum Capital Group, the sole managing underwriter, in the offering. The offering is expected to generate approximately $12 million in gross proceeds before deducting underwriting discounts and commissions and expenses.